

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proline biosynthetic process (GO:0006561) | 8.60748253 |
| 2 | DNA deamination (GO:0045006) | 7.71317801 |
| 3 | transcription from mitochondrial promoter (GO:0006390) | 7.63619945 |
| 4 | replication fork processing (GO:0031297) | 6.66205044 |
| 5 | proline metabolic process (GO:0006560) | 6.62277225 |
| 6 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 5.62296011 |
| 7 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 5.55754655 |
| 8 | formation of translation preinitiation complex (GO:0001731) | 5.46985196 |
| 9 | embryonic process involved in female pregnancy (GO:0060136) | 5.29923239 |
| 10 | viral mRNA export from host cell nucleus (GO:0046784) | 5.07361868 |
| 11 | positive regulation of protein homooligomerization (GO:0032464) | 4.94268535 |
| 12 | mitochondrial DNA metabolic process (GO:0032042) | 4.88314241 |
| 13 | chaperone-mediated protein transport (GO:0072321) | 4.64142819 |
| 14 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 4.57637534 |
| 15 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 4.57637534 |
| 16 | DNA strand renaturation (GO:0000733) | 4.51438524 |
| 17 | establishment of apical/basal cell polarity (GO:0035089) | 4.45783139 |
| 18 | mitotic G1 DNA damage checkpoint (GO:0031571) | 4.39181468 |
| 19 | GDP-mannose metabolic process (GO:0019673) | 4.25350881 |
| 20 | cullin deneddylation (GO:0010388) | 4.23951733 |
| 21 | DNA integration (GO:0015074) | 4.21182533 |
| 22 | oxidative demethylation (GO:0070989) | 4.20438551 |
| 23 | regulation of protein homooligomerization (GO:0032462) | 4.17716172 |
| 24 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.16849317 |
| 25 | protein maturation by protein folding (GO:0022417) | 4.16093485 |
| 26 | regulation of integrin activation (GO:0033623) | 4.14918789 |
| 27 | proteasome assembly (GO:0043248) | 4.13286726 |
| 28 | maturation of 5.8S rRNA (GO:0000460) | 4.04811088 |
| 29 | protein deneddylation (GO:0000338) | 4.01581470 |
| 30 | G1 DNA damage checkpoint (GO:0044783) | 3.89323632 |
| 31 | mRNA cleavage (GO:0006379) | 3.87011798 |
| 32 | mitotic G1/S transition checkpoint (GO:0044819) | 3.86246024 |
| 33 | negative regulation of JAK-STAT cascade (GO:0046426) | 3.85984802 |
| 34 | mitochondrial RNA metabolic process (GO:0000959) | 3.85151923 |
| 35 | regulation of mitochondrial translation (GO:0070129) | 3.84644174 |
| 36 | poly(A)+ mRNA export from nucleus (GO:0016973) | 3.84310905 |
| 37 | establishment of monopolar cell polarity (GO:0061162) | 3.81911425 |
| 38 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 3.81911425 |
| 39 | protein neddylation (GO:0045116) | 3.78995877 |
| 40 | non-recombinational repair (GO:0000726) | 3.77009921 |
| 41 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.77009921 |
| 42 | rRNA modification (GO:0000154) | 3.74181578 |
| 43 | negative regulation of ligase activity (GO:0051352) | 3.72615804 |
| 44 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.72615804 |
| 45 | base-excision repair (GO:0006284) | 3.70247315 |
| 46 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.67977298 |
| 47 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.67734884 |
| 48 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.67721196 |
| 49 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.67692557 |
| 50 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.64243621 |
| 51 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 3.61679119 |
| 52 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.57705059 |
| 53 | DNA double-strand break processing (GO:0000729) | 3.56241270 |
| 54 | ribosome biogenesis (GO:0042254) | 3.56159788 |
| 55 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.55388357 |
| 56 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.53827995 |
| 57 | telomere maintenance via recombination (GO:0000722) | 3.48984044 |
| 58 | DNA strand elongation (GO:0022616) | 3.47458447 |
| 59 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.45993325 |
| 60 | pseudouridine synthesis (GO:0001522) | 3.43840464 |
| 61 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.42237519 |
| 62 | base-excision repair, AP site formation (GO:0006285) | 3.38179645 |
| 63 | negative regulation of cell cycle arrest (GO:0071157) | 3.36911716 |
| 64 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.31333136 |
| 65 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.31167308 |
| 66 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.31167308 |
| 67 | termination of RNA polymerase II transcription (GO:0006369) | 3.29268566 |
| 68 | DNA ligation (GO:0006266) | 3.28624144 |
| 69 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.27626027 |
| 70 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.27626027 |
| 71 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.27626027 |
| 72 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.27068915 |
| 73 | termination of RNA polymerase III transcription (GO:0006386) | 3.26437085 |
| 74 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.26437085 |
| 75 | protein complex biogenesis (GO:0070271) | 3.26339238 |
| 76 | single strand break repair (GO:0000012) | 3.23954250 |
| 77 | regulation of translational fidelity (GO:0006450) | 3.22631864 |
| 78 | rRNA processing (GO:0006364) | 3.20967336 |
| 79 | spliceosomal snRNP assembly (GO:0000387) | 3.20882511 |
| 80 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.19157430 |
| 81 | pyrimidine-containing compound salvage (GO:0008655) | 3.19058689 |
| 82 | pyrimidine nucleoside salvage (GO:0043097) | 3.19058689 |
| 83 | cytochrome complex assembly (GO:0017004) | 3.18201146 |
| 84 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.17891667 |
| 85 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.17891667 |
| 86 | mitotic nuclear envelope reassembly (GO:0007084) | 3.17739201 |
| 87 | nuclear envelope reassembly (GO:0031468) | 3.17739201 |
| 88 | kinetochore assembly (GO:0051382) | 3.17672660 |
| 89 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.17448660 |
| 90 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.14547677 |
| 91 | protein localization to mitochondrion (GO:0070585) | 3.13969965 |
| 92 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.10524310 |
| 93 | NIK/NF-kappaB signaling (GO:0038061) | 3.08850340 |
| 94 | rRNA methylation (GO:0031167) | 3.08849525 |
| 95 | positive regulation of developmental pigmentation (GO:0048087) | 3.08690708 |
| 96 | ATP synthesis coupled proton transport (GO:0015986) | 3.08500068 |
| 97 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.08500068 |
| 98 | mitochondrial DNA replication (GO:0006264) | 3.07948355 |
| 99 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.07680334 |
| 100 | rRNA metabolic process (GO:0016072) | 3.06900914 |
| 101 | positive regulation of ligase activity (GO:0051351) | 3.06087664 |
| 102 | labyrinthine layer development (GO:0060711) | 3.05189439 |
| 103 | nucleobase biosynthetic process (GO:0046112) | 3.04491982 |
| 104 | nucleoside salvage (GO:0043174) | 3.03666656 |
| 105 | translational initiation (GO:0006413) | 3.02198472 |
| 106 | purine nucleobase biosynthetic process (GO:0009113) | 3.01715175 |
| 107 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.00626447 |
| 108 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.98857307 |
| 109 | telomere maintenance via telomere lengthening (GO:0010833) | 2.96878852 |
| 110 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.94726559 |
| 111 | cellular response to ATP (GO:0071318) | 2.94717192 |
| 112 | positive regulation of chromosome segregation (GO:0051984) | 2.91611576 |
| 113 | respiratory chain complex IV assembly (GO:0008535) | 2.91068290 |
| 114 | positive regulation of DNA repair (GO:0045739) | 2.90828271 |
| 115 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.89514076 |
| 116 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.89514076 |
| 117 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.89514076 |
| 118 | meiotic chromosome segregation (GO:0045132) | 2.89480808 |
| 119 | mitotic recombination (GO:0006312) | 2.89212672 |
| 120 | metallo-sulfur cluster assembly (GO:0031163) | 2.88896758 |
| 121 | iron-sulfur cluster assembly (GO:0016226) | 2.88896758 |
| 122 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.88646966 |
| 123 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.88646966 |
| 124 | NADH dehydrogenase complex assembly (GO:0010257) | 2.88646966 |
| 125 | embryonic placenta development (GO:0001892) | 2.88581879 |
| 126 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.87169416 |
| 127 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.87139556 |
| 128 | respiratory electron transport chain (GO:0022904) | 2.86609893 |
| 129 | trophectodermal cell differentiation (GO:0001829) | 2.85641947 |
| 130 | resolution of meiotic recombination intermediates (GO:0000712) | 2.84991625 |
| 131 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.83885459 |
| 132 | negative regulation of Ras GTPase activity (GO:0034261) | 2.83884355 |
| 133 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.81908269 |
| 134 | positive regulation by host of viral transcription (GO:0043923) | 2.81754923 |
| 135 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.80554423 |
| 136 | negative regulation of protein ubiquitination (GO:0031397) | 2.80146515 |
| 137 | response to peptidoglycan (GO:0032494) | 2.79887692 |
| 138 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.78974708 |
| 139 | establishment of protein localization to mitochondrion (GO:0072655) | 2.78900784 |
| 140 | protein targeting to mitochondrion (GO:0006626) | 2.78730931 |
| 141 | electron transport chain (GO:0022900) | 2.78088855 |
| 142 | positive regulation of prostaglandin secretion (GO:0032308) | 2.78030223 |
| 143 | GTP biosynthetic process (GO:0006183) | 2.77891859 |
| 144 | regulation of ligase activity (GO:0051340) | 2.77548775 |
| 145 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.75619869 |
| 146 | regulation of cellular amine metabolic process (GO:0033238) | 2.72023531 |
| 147 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.71936546 |
| 148 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.71236612 |
| 149 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.70219001 |
| 150 | regulation of RNA export from nucleus (GO:0046831) | 2.69772055 |
| 151 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.69388222 |
| 152 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.69248116 |
| 153 | regulation of double-strand break repair (GO:2000779) | 2.68214672 |
| 154 | L-methionine salvage (GO:0071267) | 2.67834850 |
| 155 | L-methionine biosynthetic process (GO:0071265) | 2.67834850 |
| 156 | amino acid salvage (GO:0043102) | 2.67834850 |
| 157 | oxidative phosphorylation (GO:0006119) | 2.67258969 |
| 158 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.66982590 |
| 159 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.66816875 |
| 160 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.66816875 |
| 161 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.64786776 |
| 162 | pentose metabolic process (GO:0019321) | 2.64119006 |
| 163 | establishment of viral latency (GO:0019043) | 2.61795450 |
| 164 | 7-methylguanosine mRNA capping (GO:0006370) | 2.60969264 |
| 165 | peptidyl-histidine modification (GO:0018202) | 2.60613588 |
| 166 | regulation of superoxide anion generation (GO:0032928) | 2.59956165 |
| 167 | amino sugar catabolic process (GO:0046348) | 2.59788361 |
| 168 | positive regulation of cell cycle arrest (GO:0071158) | 2.59338517 |
| 169 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.58594085 |
| 170 | nucleotide salvage (GO:0043173) | 2.57144715 |
| 171 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.56346622 |
| 172 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.56346622 |
| 173 | deoxyribonucleotide catabolic process (GO:0009264) | 2.56192102 |
| 174 | negative regulation of mitochondrion organization (GO:0010823) | 2.54996631 |
| 175 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.54757779 |
| 176 | phagosome maturation (GO:0090382) | 2.53591522 |
| 177 | UTP biosynthetic process (GO:0006228) | 2.52484793 |
| 178 | viral protein processing (GO:0019082) | 2.52331711 |
| 179 | RNA capping (GO:0036260) | 2.50666797 |
| 180 | 7-methylguanosine RNA capping (GO:0009452) | 2.50666797 |
| 181 | deoxyribose phosphate catabolic process (GO:0046386) | 2.49749306 |
| 182 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.49547224 |
| 183 | inner mitochondrial membrane organization (GO:0007007) | 2.49255756 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.87583873 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.27386570 |
| 3 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.23341101 |
| 4 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.02194739 |
| 5 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.93271408 |
| 6 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.84182979 |
| 7 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.82052076 |
| 8 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.66985470 |
| 9 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.61149075 |
| 10 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.60551765 |
| 11 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.55406862 |
| 12 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.49548137 |
| 13 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.45697081 |
| 14 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.45680888 |
| 15 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.39363695 |
| 16 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.39363695 |
| 17 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.39363695 |
| 18 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.34252603 |
| 19 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.16595691 |
| 20 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.15275923 |
| 21 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.13648281 |
| 22 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.10691729 |
| 23 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.10394221 |
| 24 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.03239147 |
| 25 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 2.02859195 |
| 26 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.02320348 |
| 27 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.01916432 |
| 28 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.01405688 |
| 29 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.00140337 |
| 30 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.98894375 |
| 31 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.98468074 |
| 32 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96421590 |
| 33 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.91721115 |
| 34 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.89752159 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.89637012 |
| 36 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.88262153 |
| 37 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.86180529 |
| 38 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.81673304 |
| 39 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.80612036 |
| 40 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.79044174 |
| 41 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.78882765 |
| 42 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.76340364 |
| 43 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.72757245 |
| 44 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.72238360 |
| 45 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.69780874 |
| 46 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.69277666 |
| 47 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.68361035 |
| 48 | * POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.67486884 |
| 49 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.67388671 |
| 50 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.66659219 |
| 51 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.63863193 |
| 52 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.61243751 |
| 53 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.60335041 |
| 54 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.59107218 |
| 55 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.57214968 |
| 56 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.56459869 |
| 57 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.56175882 |
| 58 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.55948445 |
| 59 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.55251850 |
| 60 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55214747 |
| 61 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.52175697 |
| 62 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.51895424 |
| 63 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.51456629 |
| 64 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.50867104 |
| 65 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.50847503 |
| 66 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.50227953 |
| 67 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.50027195 |
| 68 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.48086602 |
| 69 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.47831718 |
| 70 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.47408284 |
| 71 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.46310270 |
| 72 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.45289037 |
| 73 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.44039212 |
| 74 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.43864497 |
| 75 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.40085213 |
| 76 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.39094347 |
| 77 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.37274796 |
| 78 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.36574006 |
| 79 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.36530747 |
| 80 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.32161125 |
| 81 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.30785124 |
| 82 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.30713986 |
| 83 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.30347093 |
| 84 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.30073620 |
| 85 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.29213423 |
| 86 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.27810949 |
| 87 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.26338161 |
| 88 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.25177698 |
| 89 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.24915149 |
| 90 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22068980 |
| 91 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.20930111 |
| 92 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.20209620 |
| 93 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.19569871 |
| 94 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.19295610 |
| 95 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.17962757 |
| 96 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.17249152 |
| 97 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.16924780 |
| 98 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.16843315 |
| 99 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.14756448 |
| 100 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.13772877 |
| 101 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.13498906 |
| 102 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.13377633 |
| 103 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.13359492 |
| 104 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.13031405 |
| 105 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.12173546 |
| 106 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.11924234 |
| 107 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.11085503 |
| 108 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.10299897 |
| 109 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09718430 |
| 110 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.09508510 |
| 111 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.09073624 |
| 112 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.09018239 |
| 113 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.08104750 |
| 114 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.07596974 |
| 115 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.07571192 |
| 116 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.07116205 |
| 117 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06908300 |
| 118 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.06672267 |
| 119 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06516376 |
| 120 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06172345 |
| 121 | MYC_22102868_ChIP-Seq_BL_Human | 1.06165812 |
| 122 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05825441 |
| 123 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.05533533 |
| 124 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.05120789 |
| 125 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.04227012 |
| 126 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.03026119 |
| 127 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.02903483 |
| 128 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 1.02683590 |
| 129 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.02045737 |
| 130 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.01653576 |
| 131 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.00956816 |
| 132 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.00840959 |
| 133 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.00547940 |
| 134 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.00258076 |
| 135 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.99979325 |
| 136 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99840076 |
| 137 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99488264 |
| 138 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.99472312 |
| 139 | MAF_26560356_Chip-Seq_TH2_Human | 0.99061185 |
| 140 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.99051338 |
| 141 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.98799793 |
| 142 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.98626141 |
| 143 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.98594440 |
| 144 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.96926576 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008057_abnormal_DNA_replication | 6.10259441 |
| 2 | MP0005171_absent_coat_pigmentation | 3.98844254 |
| 3 | MP0003693_abnormal_embryo_hatching | 3.62496770 |
| 4 | MP0010030_abnormal_orbit_morphology | 3.49363017 |
| 5 | MP0004957_abnormal_blastocyst_morpholog | 3.40328485 |
| 6 | MP0009278_abnormal_bone_marrow | 3.20144015 |
| 7 | MP0010094_abnormal_chromosome_stability | 3.13870635 |
| 8 | MP0004233_abnormal_muscle_weight | 3.08176218 |
| 9 | MP0002148_abnormal_hypersensitivity_rea | 2.93732714 |
| 10 | MP0003436_decreased_susceptibility_to | 2.91975385 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.86095022 |
| 12 | MP0003111_abnormal_nucleus_morphology | 2.79202141 |
| 13 | MP0003786_premature_aging | 2.72547858 |
| 14 | MP0009785_altered_susceptibility_to | 2.67296423 |
| 15 | MP0003718_maternal_effect | 2.53125224 |
| 16 | MP0008058_abnormal_DNA_repair | 2.46684134 |
| 17 | MP0001853_heart_inflammation | 2.42503631 |
| 18 | MP0006082_CNS_inflammation | 2.37992916 |
| 19 | MP0008932_abnormal_embryonic_tissue | 2.37674709 |
| 20 | MP0000343_altered_response_to | 2.36903372 |
| 21 | MP0008995_early_reproductive_senescence | 2.32097355 |
| 22 | MP0003724_increased_susceptibility_to | 2.30796128 |
| 23 | MP0002653_abnormal_ependyma_morphology | 2.26996679 |
| 24 | MP0003077_abnormal_cell_cycle | 2.24381261 |
| 25 | MP0003303_peritoneal_inflammation | 2.12083554 |
| 26 | MP0005451_abnormal_body_composition | 2.11224082 |
| 27 | MP0001835_abnormal_antigen_presentation | 2.09988197 |
| 28 | MP0005000_abnormal_immune_tolerance | 2.08215663 |
| 29 | MP0002009_preneoplasia | 2.07399036 |
| 30 | MP0004133_heterotaxia | 2.05786051 |
| 31 | MP0002419_abnormal_innate_immunity | 2.04955962 |
| 32 | MP0005671_abnormal_response_to | 2.03527948 |
| 33 | MP0005025_abnormal_response_to | 1.95486336 |
| 34 | MP0003890_abnormal_embryonic-extraembry | 1.94699480 |
| 35 | MP0001545_abnormal_hematopoietic_system | 1.90613788 |
| 36 | MP0005397_hematopoietic_system_phenotyp | 1.90613788 |
| 37 | MP0008877_abnormal_DNA_methylation | 1.90161105 |
| 38 | MP0000685_abnormal_immune_system | 1.87046330 |
| 39 | MP0006072_abnormal_retinal_apoptosis | 1.84555556 |
| 40 | MP0003075_altered_response_to | 1.78691617 |
| 41 | MP0002452_abnormal_antigen_presenting | 1.78406676 |
| 42 | MP0003119_abnormal_digestive_system | 1.76747821 |
| 43 | MP0002723_abnormal_immune_serum | 1.74134346 |
| 44 | MP0001697_abnormal_embryo_size | 1.72253797 |
| 45 | MP0003806_abnormal_nucleotide_metabolis | 1.72224510 |
| 46 | MP0004510_myositis | 1.71983546 |
| 47 | MP0001790_abnormal_immune_system | 1.69959852 |
| 48 | MP0005387_immune_system_phenotype | 1.69959852 |
| 49 | MP0005058_abnormal_lysosome_morphology | 1.68060280 |
| 50 | MP0001293_anophthalmia | 1.67648009 |
| 51 | MP0005075_abnormal_melanosome_morpholog | 1.65814770 |
| 52 | MP0006035_abnormal_mitochondrial_morpho | 1.63690573 |
| 53 | MP0001730_embryonic_growth_arrest | 1.60436417 |
| 54 | MP0009764_decreased_sensitivity_to | 1.60148025 |
| 55 | MP0001533_abnormal_skeleton_physiology | 1.58301755 |
| 56 | MP0001845_abnormal_inflammatory_respons | 1.51978304 |
| 57 | MP0001819_abnormal_immune_cell | 1.51476458 |
| 58 | MP0002420_abnormal_adaptive_immunity | 1.50425774 |
| 59 | MP0005174_abnormal_tail_pigmentation | 1.49960955 |
| 60 | MP0008469_abnormal_protein_level | 1.48983634 |
| 61 | MP0002086_abnormal_extraembryonic_tissu | 1.47207235 |
| 62 | MP0002084_abnormal_developmental_patter | 1.44816599 |
| 63 | MP0001800_abnormal_humoral_immune | 1.44710879 |
| 64 | MP0002085_abnormal_embryonic_tissue | 1.43743714 |
| 65 | MP0005380_embryogenesis_phenotype | 1.42232222 |
| 66 | MP0001672_abnormal_embryogenesis/_devel | 1.42232222 |
| 67 | MP0002277_abnormal_respiratory_mucosa | 1.41700882 |
| 68 | MP0002254_reproductive_system_inflammat | 1.41425970 |
| 69 | MP0005464_abnormal_platelet_physiology | 1.40943003 |
| 70 | MP0002837_dystrophic_cardiac_calcinosis | 1.40535485 |
| 71 | MP0003567_abnormal_fetal_cardiomyocyte | 1.39242403 |
| 72 | MP0000858_altered_metastatic_potential | 1.37902248 |
| 73 | MP0002405_respiratory_system_inflammati | 1.36916625 |
| 74 | MP0009840_abnormal_foam_cell | 1.36382057 |
| 75 | MP0003283_abnormal_digestive_organ | 1.36095286 |
| 76 | MP0000350_abnormal_cell_proliferation | 1.36012295 |
| 77 | MP0000490_abnormal_crypts_of | 1.35193037 |
| 78 | MP0003136_yellow_coat_color | 1.34968365 |
| 79 | MP0002877_abnormal_melanocyte_morpholog | 1.28646730 |
| 80 | MP0003453_abnormal_keratinocyte_physiol | 1.27710052 |
| 81 | MP0002080_prenatal_lethality | 1.26793852 |
| 82 | MP0005310_abnormal_salivary_gland | 1.25233263 |
| 83 | MP0000604_amyloidosis | 1.23136070 |
| 84 | MP0000015_abnormal_ear_pigmentation | 1.22611806 |
| 85 | MP0002269_muscular_atrophy | 1.21315703 |
| 86 | MP0004197_abnormal_fetal_growth/weight/ | 1.18933652 |
| 87 | MP0005165_increased_susceptibility_to | 1.16425139 |
| 88 | MP0003656_abnormal_erythrocyte_physiolo | 1.15049344 |
| 89 | MP0000716_abnormal_immune_system | 1.14994314 |
| 90 | MP0002796_impaired_skin_barrier | 1.14837300 |
| 91 | MP0005266_abnormal_metabolism | 1.13358855 |
| 92 | MP0002282_abnormal_trachea_morphology | 1.13231934 |
| 93 | MP0009333_abnormal_splenocyte_physiolog | 1.12630380 |
| 94 | MP0000750_abnormal_muscle_regeneration | 1.12316703 |
| 95 | MP0002249_abnormal_larynx_morphology | 1.10806875 |
| 96 | MP0001542_abnormal_bone_strength | 1.10137364 |
| 97 | MP0000371_diluted_coat_color | 1.10086230 |
| 98 | MP0002429_abnormal_blood_cell | 1.09904502 |
| 99 | MP0000689_abnormal_spleen_morphology | 1.08356205 |
| 100 | MP0001727_abnormal_embryo_implantation | 1.06970935 |
| 101 | MP0003984_embryonic_growth_retardation | 1.06932164 |
| 102 | MP0004947_skin_inflammation | 1.04919041 |
| 103 | MP0000462_abnormal_digestive_system | 1.04782518 |
| 104 | MP0002111_abnormal_tail_morphology | 1.04720549 |
| 105 | MP0002019_abnormal_tumor_incidence | 1.03879775 |
| 106 | MP0002722_abnormal_immune_system | 1.03458235 |
| 107 | MP0000579_abnormal_nail_morphology | 1.03412212 |
| 108 | MP0002088_abnormal_embryonic_growth/wei | 1.03003537 |
| 109 | MP0002398_abnormal_bone_marrow | 1.00733217 |
| 110 | MP0003448_altered_tumor_morphology | 1.00599583 |
| 111 | MP0005395_other_phenotype | 1.00174237 |
| 112 | MP0010352_gastrointestinal_tract_polyps | 0.99764419 |
| 113 | MP0000313_abnormal_cell_death | 0.98999329 |
| 114 | MP0003123_paternal_imprinting | 0.98166743 |
| 115 | MP0000470_abnormal_stomach_morphology | 0.97452714 |
| 116 | MP0005085_abnormal_gallbladder_physiolo | 0.96826660 |
| 117 | MP0006036_abnormal_mitochondrial_physio | 0.94081454 |
| 118 | MP0010155_abnormal_intestine_physiology | 0.93733478 |
| 119 | MP0004019_abnormal_vitamin_homeostasis | 0.93662984 |
| 120 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.92968160 |
| 121 | MP0000639_abnormal_adrenal_gland | 0.92458464 |
| 122 | MP0005319_abnormal_enzyme/_coenzyme | 0.92275950 |
| 123 | MP0004142_abnormal_muscle_tone | 0.92180127 |
| 124 | MP0001145_abnormal_male_reproductive | 0.91622292 |
| 125 | MP0009763_increased_sensitivity_to | 0.91585535 |
| 126 | MP0005166_decreased_susceptibility_to | 0.90423978 |
| 127 | MP0001340_abnormal_eyelid_morphology | 0.87487803 |
| 128 | MP0005076_abnormal_cell_differentiation | 0.87067571 |
| 129 | MP0005365_abnormal_bile_salt | 0.85936194 |
| 130 | MP0001905_abnormal_dopamine_level | 0.84565333 |
| 131 | MP0005332_abnormal_amino_acid | 0.84164447 |
| 132 | MP0003221_abnormal_cardiomyocyte_apopto | 0.84080348 |
| 133 | MP0003828_pulmonary_edema | 0.82455473 |
| 134 | MP0000762_abnormal_tongue_morphology | 0.81238667 |
| 135 | MP0003941_abnormal_skin_development | 0.80854890 |
| 136 | MP0001764_abnormal_homeostasis | 0.79669113 |
| 137 | MP0002332_abnormal_exercise_endurance | 0.78844677 |
| 138 | MP0002938_white_spotting | 0.78661873 |
| 139 | MP0005501_abnormal_skin_physiology | 0.77028372 |
| 140 | MP0000358_abnormal_cell_content/ | 0.76720659 |
| 141 | MP0000372_irregular_coat_pigmentation | 0.76393287 |
| 142 | MP0009765_abnormal_xenobiotic_induced | 0.76126333 |
| 143 | MP0003186_abnormal_redox_activity | 0.75928082 |
| 144 | MP0001186_pigmentation_phenotype | 0.75181069 |
| 145 | MP0002075_abnormal_coat/hair_pigmentati | 0.73673632 |
| 146 | MP0003646_muscle_fatigue | 0.73560668 |
| 147 | MP0002132_abnormal_respiratory_system | 0.73520157 |
| 148 | MP0002998_abnormal_bone_remodeling | 0.72569986 |
| 149 | MP0002210_abnormal_sex_determination | 0.72291413 |
| 150 | MP0003329_amyloid_beta_deposits | 0.72157516 |
| 151 | MP0003172_abnormal_lysosome_physiology | 0.70389124 |
| 152 | MP0000609_abnormal_liver_physiology | 0.69704034 |
| 153 | MP0008007_abnormal_cellular_replicative | 0.69606397 |
| 154 | MP0000703_abnormal_thymus_morphology | 0.69572577 |
| 155 | MP0005084_abnormal_gallbladder_morpholo | 0.69479253 |
| 156 | MP0005408_hypopigmentation | 0.69360953 |
| 157 | MP0003763_abnormal_thymus_physiology | 0.68618031 |
| 158 | MP0005390_skeleton_phenotype | 0.68600546 |
| 159 | MP0008260_abnormal_autophagy | 0.67485138 |
| 160 | MP0005376_homeostasis/metabolism_phenot | 0.67272669 |
| 161 | MP0001929_abnormal_gametogenesis | 0.66099602 |
| 162 | MP0000653_abnormal_sex_gland | 0.65945211 |
| 163 | MP0005330_cardiomyopathy | 0.65595838 |
| 164 | MP0004264_abnormal_extraembryonic_tissu | 0.65190529 |
| 165 | MP0005367_renal/urinary_system_phenotyp | 0.62680753 |
| 166 | MP0000516_abnormal_urinary_system | 0.62680753 |
| 167 | MP0002163_abnormal_gland_morphology | 0.62611964 |
| 168 | MP0002114_abnormal_axial_skeleton | 0.62041209 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Concave nail (HP:0001598) | 5.13075235 |
| 2 | Pustule (HP:0200039) | 4.69869329 |
| 3 | Rib fusion (HP:0000902) | 4.49287850 |
| 4 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 4.49217912 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.48992274 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.48992274 |
| 7 | Abnormality of glycolipid metabolism (HP:0010969) | 4.48992274 |
| 8 | Rectal fistula (HP:0100590) | 4.39127903 |
| 9 | Rectovaginal fistula (HP:0000143) | 4.39127903 |
| 10 | Facial hemangioma (HP:0000329) | 4.38927318 |
| 11 | Acute necrotizing encephalopathy (HP:0006965) | 4.38257448 |
| 12 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.21004045 |
| 13 | Vacuolated lymphocytes (HP:0001922) | 4.11027154 |
| 14 | Increased IgM level (HP:0003496) | 4.05994843 |
| 15 | Mitochondrial inheritance (HP:0001427) | 4.02108074 |
| 16 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.01827828 |
| 17 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.01827828 |
| 18 | Acute encephalopathy (HP:0006846) | 3.92117968 |
| 19 | Absent radius (HP:0003974) | 3.89353623 |
| 20 | Vaginal fistula (HP:0004320) | 3.85527200 |
| 21 | Tongue fasciculations (HP:0001308) | 3.80242043 |
| 22 | Alopecia of scalp (HP:0002293) | 3.74629894 |
| 23 | Annular pancreas (HP:0001734) | 3.72605786 |
| 24 | Intestinal fistula (HP:0100819) | 3.71129479 |
| 25 | Increased CSF lactate (HP:0002490) | 3.69865812 |
| 26 | Hepatocellular necrosis (HP:0001404) | 3.69644284 |
| 27 | Dysautonomia (HP:0002459) | 3.68635929 |
| 28 | Absent forearm bone (HP:0003953) | 3.64211624 |
| 29 | Aplasia involving forearm bones (HP:0009822) | 3.64211624 |
| 30 | Poikiloderma (HP:0001029) | 3.58286365 |
| 31 | Aplasia/hypoplasia of the humerus (HP:0006507) | 3.49770390 |
| 32 | Cerebral hypomyelination (HP:0006808) | 3.49531502 |
| 33 | Progressive macrocephaly (HP:0004481) | 3.45174464 |
| 34 | Muscle fibrillation (HP:0010546) | 3.45064811 |
| 35 | Squamous cell carcinoma (HP:0002860) | 3.33786709 |
| 36 | Absent thumb (HP:0009777) | 3.33529333 |
| 37 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.32444616 |
| 38 | Renal Fanconi syndrome (HP:0001994) | 3.31085815 |
| 39 | Turricephaly (HP:0000262) | 3.30297152 |
| 40 | Abnormal hemoglobin (HP:0011902) | 3.28347410 |
| 41 | Loss of speech (HP:0002371) | 3.26446951 |
| 42 | Hepatic necrosis (HP:0002605) | 3.22353825 |
| 43 | Patellar aplasia (HP:0006443) | 3.21554317 |
| 44 | Breast hypoplasia (HP:0003187) | 3.20587901 |
| 45 | Short humerus (HP:0005792) | 3.20060175 |
| 46 | Increased cerebral lipofuscin (HP:0011813) | 3.19132533 |
| 47 | Increased hepatocellular lipid droplets (HP:0006565) | 3.17342870 |
| 48 | Increased intramyocellular lipid droplets (HP:0012240) | 3.17342435 |
| 49 | Lipid accumulation in hepatocytes (HP:0006561) | 3.12782207 |
| 50 | Hepatosplenomegaly (HP:0001433) | 3.12514012 |
| 51 | Coronal craniosynostosis (HP:0004440) | 3.07617093 |
| 52 | Orthostatic hypotension (HP:0001278) | 3.07252691 |
| 53 | Abnormality of macrophages (HP:0004311) | 3.06984089 |
| 54 | Type I transferrin isoform profile (HP:0003642) | 3.05023772 |
| 55 | Aplasia/Hypoplasia of the patella (HP:0006498) | 3.00925612 |
| 56 | Ulnar bowing (HP:0003031) | 3.00481129 |
| 57 | Male infertility (HP:0003251) | 3.00308295 |
| 58 | Increased muscle lipid content (HP:0009058) | 2.99143230 |
| 59 | Premature graying of hair (HP:0002216) | 2.96446340 |
| 60 | Intestinal atresia (HP:0011100) | 2.95596187 |
| 61 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.94179199 |
| 62 | Increased serum lactate (HP:0002151) | 2.88983858 |
| 63 | Hypochromic microcytic anemia (HP:0004840) | 2.88166221 |
| 64 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.87415677 |
| 65 | Petechiae (HP:0000967) | 2.86578776 |
| 66 | Lactic acidosis (HP:0003128) | 2.84338722 |
| 67 | Abnormality of the aortic arch (HP:0012303) | 2.79733625 |
| 68 | Alacrima (HP:0000522) | 2.79518635 |
| 69 | Cerebral edema (HP:0002181) | 2.79235623 |
| 70 | Abnormality of male internal genitalia (HP:0000022) | 2.78572922 |
| 71 | Aplasia of the musculature (HP:0100854) | 2.78275123 |
| 72 | Short chin (HP:0000331) | 2.76523812 |
| 73 | Selective tooth agenesis (HP:0001592) | 2.74248083 |
| 74 | Abnormal trabecular bone morphology (HP:0100671) | 2.72301568 |
| 75 | Abnormal protein glycosylation (HP:0012346) | 2.71805008 |
| 76 | Abnormal glycosylation (HP:0012345) | 2.71805008 |
| 77 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.71805008 |
| 78 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.71805008 |
| 79 | Respiratory failure (HP:0002878) | 2.69705002 |
| 80 | Anteriorly placed anus (HP:0001545) | 2.68358948 |
| 81 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.66098213 |
| 82 | Abnormality of the labia minora (HP:0012880) | 2.65995842 |
| 83 | Diaphragmatic weakness (HP:0009113) | 2.65725646 |
| 84 | Hypoplasia of the radius (HP:0002984) | 2.64097203 |
| 85 | Exertional dyspnea (HP:0002875) | 2.62991225 |
| 86 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.62375119 |
| 87 | Vertebral hypoplasia (HP:0008417) | 2.62375119 |
| 88 | Large for gestational age (HP:0001520) | 2.62327091 |
| 89 | Broad alveolar ridges (HP:0000187) | 2.57521004 |
| 90 | Ragged-red muscle fibers (HP:0003200) | 2.56937790 |
| 91 | Progressive neurologic deterioration (HP:0002344) | 2.56025673 |
| 92 | Congenital hip dislocation (HP:0001374) | 2.54279436 |
| 93 | Exercise intolerance (HP:0003546) | 2.52585894 |
| 94 | Albinism (HP:0001022) | 2.51109535 |
| 95 | Hypokinesia (HP:0002375) | 2.48601113 |
| 96 | Premature skin wrinkling (HP:0100678) | 2.47891766 |
| 97 | Recurrent abscess formation (HP:0002722) | 2.46853871 |
| 98 | Prolonged neonatal jaundice (HP:0006579) | 2.44792353 |
| 99 | Muscle fiber atrophy (HP:0100295) | 2.42912964 |
| 100 | Capillary hemangiomas (HP:0005306) | 2.39986392 |
| 101 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.38444232 |
| 102 | Increased serum ferritin (HP:0003281) | 2.36553411 |
| 103 | Birth length less than 3rd percentile (HP:0003561) | 2.35963465 |
| 104 | Reduced antithrombin III activity (HP:0001976) | 2.35123311 |
| 105 | Choanal stenosis (HP:0000452) | 2.34172829 |
| 106 | Cutaneous melanoma (HP:0012056) | 2.32340114 |
| 107 | Bifid uvula (HP:0000193) | 2.31196735 |
| 108 | Respiratory difficulties (HP:0002880) | 2.30994858 |
| 109 | Hypotrichosis (HP:0001006) | 2.30746114 |
| 110 | Microvesicular hepatic steatosis (HP:0001414) | 2.29283098 |
| 111 | Type 2 muscle fiber atrophy (HP:0003554) | 2.29278774 |
| 112 | Abnormality of placental membranes (HP:0011409) | 2.28811566 |
| 113 | Amniotic constriction ring (HP:0009775) | 2.28811566 |
| 114 | Mediastinal lymphadenopathy (HP:0100721) | 2.28004144 |
| 115 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.26774149 |
| 116 | Abnormal number of erythroid precursors (HP:0012131) | 2.26180695 |
| 117 | Basal cell carcinoma (HP:0002671) | 2.25836247 |
| 118 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.25756272 |
| 119 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.24585030 |
| 120 | Systemic lupus erythematosus (HP:0002725) | 2.22573501 |
| 121 | Vertebral compression fractures (HP:0002953) | 2.21163576 |
| 122 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.19449466 |
| 123 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.19449466 |
| 124 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.19449466 |
| 125 | Axonal loss (HP:0003447) | 2.19256145 |
| 126 | 3-Methylglutaconic aciduria (HP:0003535) | 2.19247313 |
| 127 | Cholecystitis (HP:0001082) | 2.18403448 |
| 128 | Abnormal gallbladder physiology (HP:0012438) | 2.18403448 |
| 129 | Recurrent bacterial skin infections (HP:0005406) | 2.17125031 |
| 130 | Abnormality of the ileum (HP:0001549) | 2.16877874 |
| 131 | Hypertensive crisis (HP:0100735) | 2.16842729 |
| 132 | Abnormal autonomic nervous system physiology (HP:0012332) | 2.16605825 |
| 133 | Rough bone trabeculation (HP:0100670) | 2.16134187 |
| 134 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.15684602 |
| 135 | Stomatitis (HP:0010280) | 2.14171614 |
| 136 | Degeneration of anterior horn cells (HP:0002398) | 2.12990595 |
| 137 | Abnormality of the anterior horn cell (HP:0006802) | 2.12990595 |
| 138 | Amelogenesis imperfecta (HP:0000705) | 2.12908550 |
| 139 | Premature ovarian failure (HP:0008209) | 2.12609308 |
| 140 | Methylmalonic aciduria (HP:0012120) | 2.12543652 |
| 141 | Upper motor neuron abnormality (HP:0002127) | 2.11574910 |
| 142 | Opisthotonus (HP:0002179) | 2.10065193 |
| 143 | Dysostosis multiplex (HP:0000943) | 2.09487803 |
| 144 | Nuclear cataract (HP:0100018) | 2.08795486 |
| 145 | Polycythemia (HP:0001901) | 2.07240663 |
| 146 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.05767113 |
| 147 | Mucopolysacchariduria (HP:0008155) | 2.05767113 |
| 148 | Redundant skin (HP:0001582) | 2.05244942 |
| 149 | Joint stiffness (HP:0001387) | 2.04918628 |
| 150 | Mutism (HP:0002300) | 2.03831019 |
| 151 | Multiple enchondromatosis (HP:0005701) | 2.02879029 |
| 152 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.02576541 |
| 153 | Growth hormone excess (HP:0000845) | 2.01580898 |
| 154 | Aplastic anemia (HP:0001915) | 2.00055672 |
| 155 | Microretrognathia (HP:0000308) | 1.99553594 |
| 156 | Decreased lacrimation (HP:0000633) | 1.98795383 |
| 157 | Abnormality of the umbilical cord (HP:0010881) | 1.98636739 |
| 158 | Hypoplasia of the ulna (HP:0003022) | 1.97629233 |
| 159 | Clumsiness (HP:0002312) | 1.96698439 |
| 160 | Carpal bone hypoplasia (HP:0001498) | 1.92282160 |
| 161 | Lethargy (HP:0001254) | 1.92036524 |
| 162 | Oral leukoplakia (HP:0002745) | 1.91872287 |
| 163 | Aplasia/Hypoplasia of the ulna (HP:0006495) | 1.91359889 |
| 164 | Nausea (HP:0002018) | 1.90969840 |
| 165 | Gastrointestinal atresia (HP:0002589) | 1.90871853 |
| 166 | IgA deficiency (HP:0002720) | 1.90666710 |
| 167 | Pancytopenia (HP:0001876) | 1.89022577 |
| 168 | Emotional lability (HP:0000712) | 1.88458055 |
| 169 | Fasciculations (HP:0002380) | 1.87422636 |
| 170 | Median cleft lip (HP:0000161) | 1.87240459 |
| 171 | Progressive muscle weakness (HP:0003323) | 1.87235068 |
| 172 | Death in infancy (HP:0001522) | 1.86544141 |
| 173 | Hypochromic anemia (HP:0001931) | 1.86450201 |
| 174 | Premature loss of primary teeth (HP:0006323) | 1.85755654 |
| 175 | Popliteal pterygium (HP:0009756) | 1.85122030 |
| 176 | CNS demyelination (HP:0007305) | 1.84521069 |
| 177 | Optic disc pallor (HP:0000543) | 1.83295408 |
| 178 | Testicular atrophy (HP:0000029) | 1.81516767 |
| 179 | Hypotelorism (HP:0000601) | 1.80043232 |
| 180 | Obstructive lung disease (HP:0006536) | 1.80006862 |
| 181 | Chronic obstructive pulmonary disease (HP:0006510) | 1.80006862 |
| 182 | Abnormal number of incisors (HP:0011064) | 1.78302475 |
| 183 | Increased serum pyruvate (HP:0003542) | 1.77523951 |
| 184 | Impulsivity (HP:0100710) | 1.77422339 |
| 185 | Hamartoma (HP:0010566) | 1.76821153 |
| 186 | Reticulocytopenia (HP:0001896) | 1.76529269 |
| 187 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.75842613 |
| 188 | Dicarboxylic aciduria (HP:0003215) | 1.75842613 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ICK | 4.80908678 |
| 2 | MAPK15 | 4.63414855 |
| 3 | DDR2 | 4.16434223 |
| 4 | MAP3K6 | 3.77953695 |
| 5 | MAP3K11 | 3.58806390 |
| 6 | IRAK3 | 3.55241344 |
| 7 | BUB1 | 3.41553495 |
| 8 | PINK1 | 3.20065271 |
| 9 | TESK1 | 3.11148189 |
| 10 | PIM2 | 2.92454972 |
| 11 | VRK2 | 2.87179374 |
| 12 | MATK | 2.62366020 |
| 13 | AKT3 | 2.57375675 |
| 14 | FGR | 2.57316231 |
| 15 | WEE1 | 2.50004123 |
| 16 | TYRO3 | 2.18152419 |
| 17 | DAPK1 | 2.14843425 |
| 18 | YES1 | 1.99681830 |
| 19 | MST4 | 1.95866775 |
| 20 | UHMK1 | 1.92880046 |
| 21 | SIK3 | 1.91600221 |
| 22 | LIMK1 | 1.87904037 |
| 23 | CDK7 | 1.86014580 |
| 24 | ABL2 | 1.74488826 |
| 25 | PRKD2 | 1.70829223 |
| 26 | TRIM28 | 1.68005641 |
| 27 | DYRK3 | 1.67698966 |
| 28 | DYRK1B | 1.67690699 |
| 29 | ERN1 | 1.61679876 |
| 30 | EPHA2 | 1.58370110 |
| 31 | LATS2 | 1.57226112 |
| 32 | PAK4 | 1.54161669 |
| 33 | TBK1 | 1.51187177 |
| 34 | NME2 | 1.50888086 |
| 35 | BMX | 1.49297998 |
| 36 | CSK | 1.48408004 |
| 37 | PBK | 1.46292781 |
| 38 | PLK1 | 1.45516652 |
| 39 | MAP3K3 | 1.35464171 |
| 40 | PIM1 | 1.31872237 |
| 41 | KDR | 1.29229418 |
| 42 | IKBKB | 1.27921802 |
| 43 | BRSK2 | 1.27363197 |
| 44 | MAP3K12 | 1.26822713 |
| 45 | CHEK2 | 1.22268942 |
| 46 | ZAK | 1.17913876 |
| 47 | MAP3K14 | 1.09178309 |
| 48 | PDGFRA | 1.06071787 |
| 49 | RPS6KC1 | 1.02151579 |
| 50 | RPS6KL1 | 1.02151579 |
| 51 | STK16 | 1.00874061 |
| 52 | BCKDK | 1.00352460 |
| 53 | MAP2K3 | 0.99774665 |
| 54 | IRAK4 | 0.97796468 |
| 55 | AURKA | 0.97407596 |
| 56 | TESK2 | 0.95657030 |
| 57 | TAOK1 | 0.91232824 |
| 58 | PLK4 | 0.90472970 |
| 59 | TAOK2 | 0.90383246 |
| 60 | GSK3A | 0.90093506 |
| 61 | MAP4K1 | 0.89243876 |
| 62 | TYK2 | 0.88577097 |
| 63 | NEK2 | 0.88102178 |
| 64 | ILK | 0.87358084 |
| 65 | RPS6KA6 | 0.86843620 |
| 66 | DYRK2 | 0.86715397 |
| 67 | RAF1 | 0.84715800 |
| 68 | CDC42BPA | 0.83017442 |
| 69 | GRK7 | 0.82451482 |
| 70 | SMG1 | 0.81306841 |
| 71 | CDK6 | 0.78725556 |
| 72 | MAPKAPK3 | 0.76316121 |
| 73 | TRPM7 | 0.76013793 |
| 74 | TXK | 0.75325769 |
| 75 | TTK | 0.75103729 |
| 76 | CSNK2A1 | 0.73991723 |
| 77 | PHKG1 | 0.73442214 |
| 78 | PHKG2 | 0.73442214 |
| 79 | EIF2AK1 | 0.70117332 |
| 80 | RPS6KB2 | 0.69902097 |
| 81 | IKBKE | 0.69584802 |
| 82 | ATR | 0.68825126 |
| 83 | STK10 | 0.68173751 |
| 84 | SIK1 | 0.67263405 |
| 85 | MAPK11 | 0.66577172 |
| 86 | DAPK3 | 0.66431508 |
| 87 | MAP2K7 | 0.66015595 |
| 88 | BRSK1 | 0.65463663 |
| 89 | TGFBR2 | 0.65087306 |
| 90 | AURKB | 0.64326336 |
| 91 | NEK1 | 0.61741555 |
| 92 | RPS6KA5 | 0.61010149 |
| 93 | CSNK1A1L | 0.59624489 |
| 94 | MUSK | 0.59184480 |
| 95 | TLK1 | 0.58675748 |
| 96 | MAP2K2 | 0.58327415 |
| 97 | GRK6 | 0.58319669 |
| 98 | ARAF | 0.58266053 |
| 99 | CSNK1G1 | 0.57331372 |
| 100 | CSNK2A2 | 0.57324954 |
| 101 | PAK1 | 0.56963400 |
| 102 | ACVR1B | 0.56589801 |
| 103 | CAMK2B | 0.55541651 |
| 104 | CAMK2G | 0.53822757 |
| 105 | MOS | 0.51571809 |
| 106 | CDK2 | 0.51357888 |
| 107 | SRPK1 | 0.49754305 |
| 108 | RPS6KA1 | 0.48416099 |
| 109 | VRK1 | 0.47957343 |
| 110 | MAP3K5 | 0.46909466 |
| 111 | PRKAA1 | 0.46907599 |
| 112 | CSNK1G2 | 0.46608188 |
| 113 | EIF2AK3 | 0.45974879 |
| 114 | CDC7 | 0.45061124 |
| 115 | PRPF4B | 0.44230776 |
| 116 | PDK4 | 0.43400296 |
| 117 | PDK3 | 0.43400296 |
| 118 | SCYL2 | 0.43306027 |
| 119 | RPS6KA4 | 0.42860093 |
| 120 | CHEK1 | 0.42804888 |
| 121 | MTOR | 0.39881347 |
| 122 | LYN | 0.38841427 |
| 123 | LRRK2 | 0.37285319 |
| 124 | RIPK4 | 0.37173515 |
| 125 | TSSK6 | 0.37112552 |
| 126 | MAP3K8 | 0.36320926 |
| 127 | MARK3 | 0.36229943 |
| 128 | EIF2AK2 | 0.35867231 |
| 129 | BRAF | 0.35469421 |
| 130 | PRKCI | 0.35262008 |
| 131 | CSF1R | 0.34775467 |
| 132 | MAPK4 | 0.34432080 |
| 133 | STK38L | 0.33749438 |
| 134 | HIPK2 | 0.32350241 |
| 135 | STK3 | 0.32174710 |
| 136 | CDK19 | 0.31977097 |
| 137 | NME1 | 0.31924334 |
| 138 | STK4 | 0.31790139 |
| 139 | CAMK2D | 0.30219766 |
| 140 | CCNB1 | 0.30170454 |
| 141 | MAPKAPK2 | 0.29866681 |
| 142 | CDK8 | 0.28617207 |
| 143 | CDK1 | 0.27977453 |
| 144 | CHUK | 0.27832091 |
| 145 | CSNK1G3 | 0.26945637 |
| 146 | BLK | 0.26136732 |
| 147 | MAP3K9 | 0.26051733 |
| 148 | CDK11A | 0.25600399 |
| 149 | PLK3 | 0.25538747 |
| 150 | PRKG2 | 0.24839106 |
| 151 | MAPK3 | 0.24657831 |
| 152 | ATM | 0.23049755 |
| 153 | PDK2 | 0.22687309 |
| 154 | EGFR | 0.22243094 |
| 155 | CDK15 | 0.22169211 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Mismatch repair_Homo sapiens_hsa03430 | 4.46706022 |
| 2 | Base excision repair_Homo sapiens_hsa03410 | 4.13657201 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.89427860 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 3.44779497 |
| 5 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.32350771 |
| 6 | Ribosome_Homo sapiens_hsa03010 | 3.20777192 |
| 7 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 3.09258168 |
| 8 | RNA polymerase_Homo sapiens_hsa03020 | 2.93803506 |
| 9 | Spliceosome_Homo sapiens_hsa03040 | 2.72100221 |
| 10 | RNA transport_Homo sapiens_hsa03013 | 2.58298648 |
| 11 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.55763872 |
| 12 | Homologous recombination_Homo sapiens_hsa03440 | 2.29935396 |
| 13 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.17918256 |
| 14 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.05402274 |
| 15 | Sulfur relay system_Homo sapiens_hsa04122 | 2.04583562 |
| 16 | Other glycan degradation_Homo sapiens_hsa00511 | 1.84200904 |
| 17 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.83780351 |
| 18 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.80954000 |
| 19 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.80221098 |
| 20 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.77407924 |
| 21 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.73849315 |
| 22 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.73468514 |
| 23 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.70158222 |
| 24 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.66655003 |
| 25 | Cell cycle_Homo sapiens_hsa04110 | 1.61811347 |
| 26 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.59619411 |
| 27 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.56533584 |
| 28 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.48125741 |
| 29 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.47217063 |
| 30 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.46423122 |
| 31 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.44217492 |
| 32 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.38630376 |
| 33 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.24775187 |
| 34 | Circadian rhythm_Homo sapiens_hsa04710 | 1.24591449 |
| 35 | Parkinsons disease_Homo sapiens_hsa05012 | 1.23784904 |
| 36 | Basal transcription factors_Homo sapiens_hsa03022 | 1.23248636 |
| 37 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.22947781 |
| 38 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.19093772 |
| 39 | Huntingtons disease_Homo sapiens_hsa05016 | 1.12841269 |
| 40 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.12819509 |
| 41 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.12353616 |
| 42 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.11213145 |
| 43 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.10220678 |
| 44 | Allograft rejection_Homo sapiens_hsa05330 | 1.09078293 |
| 45 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.07888132 |
| 46 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.07410929 |
| 47 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.06238224 |
| 48 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.00199719 |
| 49 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.99689096 |
| 50 | Asthma_Homo sapiens_hsa05310 | 0.99279456 |
| 51 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.97759557 |
| 52 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.97043420 |
| 53 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.95476697 |
| 54 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.93114083 |
| 55 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.92597048 |
| 56 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.92162503 |
| 57 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.91167940 |
| 58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.90998191 |
| 59 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.89729034 |
| 60 | Salmonella infection_Homo sapiens_hsa05132 | 0.89714612 |
| 61 | Phagosome_Homo sapiens_hsa04145 | 0.89395194 |
| 62 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.88496855 |
| 63 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.87037751 |
| 64 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.85552275 |
| 65 | RNA degradation_Homo sapiens_hsa03018 | 0.85060300 |
| 66 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.83645374 |
| 67 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.82615402 |
| 68 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.81870335 |
| 69 | Tuberculosis_Homo sapiens_hsa05152 | 0.81407778 |
| 70 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.80997575 |
| 71 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.79247739 |
| 72 | Leishmaniasis_Homo sapiens_hsa05140 | 0.79105074 |
| 73 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.78008940 |
| 74 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.77909974 |
| 75 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.77733795 |
| 76 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.77577847 |
| 77 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.75867028 |
| 78 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.75665316 |
| 79 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.74202776 |
| 80 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.73802007 |
| 81 | Purine metabolism_Homo sapiens_hsa00230 | 0.73631214 |
| 82 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.72572111 |
| 83 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.72255282 |
| 84 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.69613202 |
| 85 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.69022404 |
| 86 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.67742821 |
| 87 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.66522365 |
| 88 | Viral myocarditis_Homo sapiens_hsa05416 | 0.66069822 |
| 89 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.62793066 |
| 90 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.62700278 |
| 91 | Bladder cancer_Homo sapiens_hsa05219 | 0.61757149 |
| 92 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.60823495 |
| 93 | Apoptosis_Homo sapiens_hsa04210 | 0.60686575 |
| 94 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.58909392 |
| 95 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.58601833 |
| 96 | Galactose metabolism_Homo sapiens_hsa00052 | 0.58566943 |
| 97 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.58425289 |
| 98 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.58301511 |
| 99 | Metabolic pathways_Homo sapiens_hsa01100 | 0.57860240 |
| 100 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.57142399 |
| 101 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.56932151 |
| 102 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.56639538 |
| 103 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.54769280 |
| 104 | Shigellosis_Homo sapiens_hsa05131 | 0.54097201 |
| 105 | Peroxisome_Homo sapiens_hsa04146 | 0.53564808 |
| 106 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.53174368 |
| 107 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.53006198 |
| 108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.52979961 |
| 109 | Pertussis_Homo sapiens_hsa05133 | 0.52363385 |
| 110 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.51316369 |
| 111 | Alzheimers disease_Homo sapiens_hsa05010 | 0.51235291 |
| 112 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.50431509 |
| 113 | Carbon metabolism_Homo sapiens_hsa01200 | 0.44560141 |
| 114 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.44008898 |
| 115 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.43565468 |
| 116 | Protein export_Homo sapiens_hsa03060 | 0.43274082 |
| 117 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.42357499 |
| 118 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.41610793 |
| 119 | Influenza A_Homo sapiens_hsa05164 | 0.40452426 |
| 120 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.40307673 |
| 121 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.38142036 |
| 122 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.37805554 |
| 123 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.37741486 |
| 124 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.34688131 |
| 125 | Adherens junction_Homo sapiens_hsa04520 | 0.34398974 |
| 126 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.33613029 |
| 127 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31889530 |
| 128 | Legionellosis_Homo sapiens_hsa05134 | 0.29906728 |
| 129 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.27444784 |
| 130 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.27303882 |
| 131 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.25477577 |
| 132 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.25276478 |
| 133 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.24826318 |
| 134 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.23463640 |
| 135 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.23326394 |
| 136 | Tight junction_Homo sapiens_hsa04530 | 0.23292420 |
| 137 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.22421716 |
| 138 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.21657744 |
| 139 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.20505469 |
| 140 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.20010658 |
| 141 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.19412261 |
| 142 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.19031640 |
| 143 | Lysosome_Homo sapiens_hsa04142 | 0.17697558 |
| 144 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.17218761 |
| 145 | Thyroid cancer_Homo sapiens_hsa05216 | 0.14258034 |
| 146 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.13969937 |
| 147 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.13751187 |

